We are live on ! Find out more
GF

Gabelli Funds Portfolio holdings

AUM $14.8B
1-Year Est. Return 32.24%
This Fund
S&P 500
This Quarter Est. Return
+18.26%
1 Year Est. Return
+32.24%
3 Year Est. Return
+88.06%
5 Year Est. Return
+130.29%
10 Year Est. Return
+486.58%
AUM
$14B
AUM Growth
+$1.2B
Cap. Flow
-$847M
Cap. Flow %
-6.04%
Top 10 Hldgs %
11.68%
Holding
1,314
New
181
Increased
195
Reduced
495
Closed
102

Sector Composition

Rank Sector Weight
1 Industrials 17.98%
2 Communication Services 12.26%
3 Utilities 11.67%
4 Financials 10.51%
5 Technology 8.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CKH
326
DELISTED
Seacor Holdings Inc.
CKH
$10.1M 0.07%
+243,812
New +$8.55M
MOD icon
327
Modine Manufacturing
MOD
$12.2B
$10.1M 0.07%
804,000
+89,000
+12% +$863K
UL icon
328
Unilever
UL
$132B
$9.89M 0.07%
145,689
+58,667
+67% +$3.98M
TU icon
329
Telus
TU
$16.2B
$9.78M 0.07%
494,000
ISRG icon
330
Intuitive Surgical
ISRG
$128B
$9.69M 0.07%
35,520
+420
+1% +$104K
AZZ icon
331
AZZ Inc
AZZ
$4.47B
$9.69M 0.07%
204,156
+6,000
+3% +$243K
DBD
332
DELISTED
Diebold Nixdorf Incorporated
DBD
$9.69M 0.07%
908,500
-25,500
-3% -$232K
NGG icon
333
National Grid
NGG
$81.6B
$9.66M 0.07%
185,106
-1,131
-0.6% -$60K
VRTU
334
DELISTED
Virtusa Corporation
VRTU
$9.63M 0.07%
188,313
+107,223
+132% +$5.38M
CHE icon
335
Chemed
CHE
$6.76B
$9.59M 0.07%
18,000
MTB icon
336
M&T Bank
MTB
$36B
$9.48M 0.07%
74,450
-4,000
-5% -$456K
TDOC icon
337
Teladoc Health
TDOC
$1.61B
$9.42M 0.07%
47,100
-200
-0.4% -$40.7K
ORA icon
338
Ormat Technologies
ORA
$6.28B
$9.31M 0.07%
103,150
BHC icon
339
Bausch Health
BHC
$1.67B
$9.26M 0.07%
445,000
-62,500
-12% -$1.17M
BATRA icon
340
Atlanta Braves Holdings Series A
BATRA
$3.53B
$9.24M 0.07%
371,624
+9,224
+3% +$220K
WY icon
341
Weyerhaeuser
WY
$17.2B
$9.21M 0.07%
274,700
-21,000
-7% -$632K
ASH icon
342
Ashland
ASH
$3.04B
$9.18M 0.07%
115,900
-8,000
-6% -$605K
NI icon
343
NiSource
NI
$22B
$9.13M 0.07%
398,000
NVS icon
344
Novartis
NVS
$297B
$9.06M 0.06%
96,000
-3,000
-3% -$262K
SYK icon
345
Stryker
SYK
$129B
$9.04M 0.06%
36,900
-2,000
-5% -$453K
TAP icon
346
Molson Coors Class B
TAP
$7.71B
$8.95M 0.06%
198,000
-10,000
-5% -$412K
BEAT
347
DELISTED
BioTelemetry, Inc.
BEAT
$8.91M 0.06%
123,631
+34,536
+39% +$1.81M
IBKR icon
348
Interactive Brokers
IBKR
$41.1B
$8.91M 0.06%
584,996
-4,000
-0.7% -$53K
ABBV icon
349
AbbVie
ABBV
$454B
$8.84M 0.06%
82,496
+16,900
+26% +$1.62M
MSCI icon
350
MSCI
MSCI
$41.5B
$8.77M 0.06%
19,640
+240
+1% +$94.2K

Similar funds

Gabelli Funds's Q4 2020 Portfolio in Review

As of Q4 2020, Gabelli Funds held 1,314 positions worth $14B, up 9.4% from $12.8B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Gabelli Funds withdrew a net $847M in Q4 2020, closing 102 positions and reducing 495 holdings. Its most notable exit was Momenta Pharmaceuticals, Inc., an estimated $73.1M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 18% of assets, up from 17% a quarter earlier, followed by Communication Services and Utilities.

Against the trend, Gabelli Funds opened a new position in Navistar International worth $48.9M.

  • Gabelli Funds's largest Q4 2020 buy was Navistar International: 1,113,333 shares worth $48.9M.
  • Gabelli Funds added most to Morgan Stanley in Q4 2020, an estimated $23.6M increase.
  • Gabelli Funds's biggest Q4 2020 reduction was Rollins, cutting an estimated $48.2M.
  • Gabelli Funds fully exited Momenta Pharmaceuticals, Inc. in Q4 2020, selling an estimated $73.1M.
  • Gabelli Funds's ten largest holdings make up 12% of its $14B portfolio in Q4 2020.
  • Gabelli Funds opened 181 new positions and closed 102 in Q4 2020.
  • Gabelli Funds's portfolio value rose 9.4% quarter-over-quarter to $14B.

Based on Gabelli Funds's 13F filing for Q4 2020, filed 5 Feb 2021.